Justin Harris

FSA, MAAA

Senior Actuarial Manager

Brookfield, WI, US

Office + 1262 784 2250 | Direct + 1 262 796 3492

Justin Harris is a senior actuarial manager with the Milwaukee office of Milliman. He joined the firm in 2010.

Justin has more than 10 years of health actuarial experience in pricing, financial reporting, strategic analysis, and regulatory analysis. His areas of expertise include Medicare Advantage, especially Part D plans, pharmacy, and general prescription drug market analytics.

Download bio

Loading component...

Experience

Justin’s Medicare Advantage and pharmacy experience includes the following:

In the Medicare Advantage market, Justin has assisted MAPDs and PDPs with strategic planning, settlement estimation, financial forecasting, and Medicare Advantage bid preparation, along with audit and desk review support.
In the pharmacy space, Justin has worked with pharmaceutical companies, industry organizations, and insurance carriers with payment strategy, regulatory issues, and forecasting, with emphasis on the Medicare Part D benefit. Additionally, Justin has worked with pharmacy benefit managers in pricing, rebate strategy and modeling, and other various analyses.
Justin is a key contributor to Milliman’s research efforts. He contributes to the review and development of various components of Milliman’s Medicare Part D suite of tools for bid preparation and the analytical review of claims experience, along with guiding research on the generic pipeline forecasting and PBM contracting in the Part D market.

In addition to Medicare Advantage and pharmacy work, Justin has worked with estimating reserves for statements of actuarial opinion, risk adjustment, and assisting state Medicaid agencies.

Professional Designations

Fellow of the Society of Actuaries
Member, Academy of Actuaries

Education

BBA, Actuarial Science, Risk Management / Insurance, and Finance, University of Wisconsin - Madison

Loading component...

Publications

Read their latest work

Article

Prescribing a Part D formulary for the new IRA world

13 December 2024 - by Madeleine Feller, Justin Harris, Jian-ya Lin, Mark F. Gruenhaupt, RPh

Medicare Part D: We highlight the changes in plan incentives and key trends in 2025 formulary coverage, along with considerations for 2026.

Article

A new Part D benefit design? Prescription Drug Pricing Reduction Act proposes major changes to Part D

15 August 2019 - by Joanna Amend, Samantha D’Anna, Dustin Grzeskowiak, Justin Harris, Matthew Hayes

This article provides an overview of the provisions in the Prescription Drug Pricing Reduction Act of 2019 and the effects on Medicare Part D stakeholders.

Article

Commercial specialty medication research: 2016 benchmark projections

06 January 2015 - by Justin Harris, Katherine M. Holcomb

This study provides specialty medication claim cost benchmarks to illustrate the magnitude and distribution of specialty medication costs adjudicated under the pharmacy and medical benefit.

Justin Harris

Loading component...

Experience

Loading component...

Read their latest work

Prescribing a Part D formulary for the new IRA world

A new Part D benefit design? Prescription Drug Pricing Reduction Act proposes major changes to Part D

Commercial specialty medication research: 2016 benchmark projections

CHOOSE A LOCATION AND LANGUAGE

Justin Harris

Experience

CHOOSE A LOCATION AND LANGUAGE